Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acidemia, isovaleric]

Y Matsubara1

  • 1Department of Medical Genetics, Tohoku University School of Medicine.

Ryoikibetsu Shokogun Shirizu
|July 21, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

ESMO open·2026
Same author

Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer.

ESMO gastrointestinal oncology·2026
Same author

Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience.

ESMO gastrointestinal oncology·2026
Same author

Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer.

ESMO gastrointestinal oncology·2026
Same author

BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for <i>BRAF</i> V600E-mutant metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer.

ESMO open·2025
Same journal

[Substance-related mental disorders and expert testimony].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Nicotine-related mental disorders].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Organic solvent-related mental disorders].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Hallucinogen related mental disorder].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Methylphenidate-induced psychiatric disorders].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Sensitization phenomenon].

Ryoikibetsu shokogun shirizu·2003
See all related articles